bioMérieux (OTCMKTS:BMXMF) Hits New 12-Month High at $122.52

bioMérieux S.A. (OTCMKTS:BMXMF) reached a new 52-week high during trading on Wednesday . The stock traded as high as $122.52 and last traded at $122.52, with a volume of 0 shares changing hands. The stock had previously closed at $122.52.

Wall Street Analyst Weigh In

Separately, UBS Group upgraded shares of bioMérieux to a “strong-buy” rating in a report on Thursday, August 22nd.

bioMérieux Stock Performance

The business’s 50 day moving average price is $106.82 and its 200-day moving average price is $105.60. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.19 and a current ratio of 2.03.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.